{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Princeton",
      "state": "NJ",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "68276",
      "recalling_firm": "Bristol-Meyers Squibb",
      "address_1": "PO Box 4000",
      "address_2": "N/A",
      "postal_code": "08543-4000",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide, Canada",
      "recall_number": "D-1595-2014",
      "product_description": "COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vial Rx Only Distributed by Bristol Meyers Squibb Company, Princeton, NJ 08543 USA NDC 0590-0324-96",
      "product_quantity": "50,724 Vials",
      "reason_for_recall": "Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vials",
      "recall_initiation_date": "20140512",
      "center_classification_date": "20140918",
      "termination_date": "20150529",
      "report_date": "20140924",
      "code_info": "Lot 00201125,  Exp. 09/14; 00201126  Exp.11/14; 00201127, Exp.12/14; 00201228 Exp.06/15; 00201229 Exp.  07/15; 00201230, Exp. 09/15",
      "more_code_info": ""
    }
  ]
}